Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News enVVeno Medical Corp NVNO

Healthcare Medical Devices
enVVeno Medical Corporation is a late-stage clinical med-tech company. The Company is focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company is developing surgical and non-surgical replacement venous valves for patients suffering from severe Chronic Venous Insufficiency (CVI) of the deep venous system... see more

Recent & Breaking News (NDAQ:NVNO)

enVVeno Medical Posts Company Highlights and Materials from 2023 VEITH Symposium

Accesswire December 14, 2023

enVVeno Medical Presents Positive Preliminary Device Related Material Adverse Event (MAE) Data from the VenoValve Pivotal Trial at the 50th Annual VEITH Symposium

Accesswire November 16, 2023

enVVeno Medical Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Accesswire October 26, 2023

enVVeno Medical to Participate at the Virtual Investor Ask the CEO Conference

Accesswire October 12, 2023

enVVeno Medical Achieves Full Enrollment for VenoValve U.S. Pivotal Trial

Accesswire October 6, 2023

enVVeno Medical Announces New Expedited Development Plan for the enVVe(R) Transcatheter Based Replacement Venous Valve

Accesswire October 6, 2023

enVVeno Medical Announces Private Placement of $28 Million

Accesswire October 6, 2023

enVVeno Medical Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Accesswire July 31, 2023

enVVeno Medical to Host Virtual KOL Event on July 18, 2023

Accesswire July 14, 2023

enVVeno Medical Provides Enrollment Update for Ongoing VenoValve(R) U.S. Pivotal Study and Announces Upcoming Investor and KOL Events

Accesswire July 5, 2023

enVVeno Medical Reports First Quarter 2023 Financial Results and Provides Corporate Update

Accesswire May 1, 2023

enVVeno Medical Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update

Accesswire March 2, 2023

enVVeno Medical to Present at Cowen's 43rd Annual Health Care Conference

Accesswire February 8, 2023

enVVeno Medical Promotes Dr. Hamed Alavi to Senior Vice President and Chief Technology Officer

Accesswire January 18, 2023

Positive 3-Year VenoValve(R) First-in-Human Data Presented at 49th Annual VEITH Symposium on Vascular and Endovascular Issues

Accesswire November 17, 2022

enVVeno Medical Successfully Passes Preliminary FDA Safety Review for the VenoValve U.S. Pivotal Study

Accesswire November 7, 2022

enVVeno Medical Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Accesswire October 27, 2022

enVVeno Medical to Present at the Ladenburg Thalmann 2022 Healthcare Conference

Accesswire September 22, 2022

enVVeno Medical to Host Conference Call and Webcast on September 21, 2022

Accesswire September 19, 2022

enVVeno Medical to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Accesswire September 12, 2022